News

Dr. Nick Medjeral-Thomas (UK) hosts this edition of the ISN Global Kidney Care Podcast. He joins fellow nephrologists Dr. Namrata Parikh (Canada) and Dr. Gary Chan (Hong Kong) to discuss the diagnosis and management of complement-mediated kidney diseases. All three are involved in developing the ISN Complement-mediated Kidney Disease Toolkit, launched in 2022.

Listen to the podcast here.

The conversation focuses on key clinical and pathology features of inappropriate, pathogenic complement activity that guide physicians to a diagnosis of C3 glomerulopathy.

Dr. Medjeral-Thomas and his guests discuss the differences in investigation and management strategies between their respective clinical centers in Ottawa, Hong Kong and London, including access to clinical trials of therapeutic complement inhibitors.

They round up the discussion by speculating on the future impact of complement pathway analysis and inhibition on clinical nephrology.

This podcast is sponsored by Novartis.